Target intelligence / Profile preview

Collagen type III alpha 1 chain mRNA 3'-untranslated region (COL3A1 mRNA 3'-UTR) (COL3A1 mRNA 3'-UTR)

Target
COL3A1 mRNA 3'-UTR
Molecular classification
RNA, Untranslated region
01

Overview

The Collagen type III alpha 1 chain (COL3A1) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the messenger RNA that encodes the alpha 1 chain of type III collagen, a fibrillar collagen essential for the structural integrity of extensible tissues like the skin, lungs, and vascular system (UniProt P02461). This 3'-UTR contains conserved binding sites for the miR-29 family of microRNAs, which act as potent repressors of collagen synthesis by promoting mRNA degradation and inhibiting translation (PMID: 18156152). In various fibrotic diseases, such as liver cirrhosis and pulmonary fibrosis, the downregulation of miR-29 leads to the pathological over-stabilization of COL3A1 mRNA and subsequent excessive collagen deposition (PMID: 21464369). Consequently, the COL3A1 mRNA 3'-UTR is a primary target for RNA-based therapeutics, including microRNA mimics like Remlarsen (MRG-201) and antisense oligonucleotides designed to reduce collagen production in fibrotic tissues (ClinicalTrials.gov NCT03601052). While targeting this region offers a promising anti-fibrotic strategy, it carries significant safety risks, as excessive suppression of COL3A1 can lead to vascular fragility and increased risk of organ rupture, mimicking the phenotype of vascular Ehlers-Danlos syndrome (PMID: 24607332). This target represents a sophisticated approach to managing extracellular matrix remodeling by intervening at the post-transcriptional level.

Other names
COL3A1 3'-UTRCollagen alpha-1(III) chain mRNA 3'-UTRAlpha-1 type III collagen mRNA 3'-UTR
02

Mechanism of action

MicroRNA-mediated translational repression and mRNA decay

03

Biological functions

Regulation of mRNA stabilityTranslation regulationPost-transcriptional gene regulation
04

Disease associations

FibrosisLiver cirrhosisPulmonary fibrosisSystemic sclerosisVascular Ehlers-Danlos syndrome
05

Safety considerations

Vascular fragilityImpaired wound healingRisk of organ ruptureOff-target RNA interference
06

Interacting drugs

Remlarsen

2 more in the full profile.

07

Biomarkers

Procollagen III N-terminal propeptide (PIIINP)COL3A1 mRNA levelsType III collagen protein levels

Beyond the preview

Go deeper on Collagen type III alpha 1 chain mRNA 3'-untranslated region (COL3A1 mRNA 3'-UTR) (COL3A1 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen type III alpha 1 chain mRNA 3'-untranslated region (COL3A1 mRNA 3'-UTR) (COL3A1 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call